Corpus Intelligence IC Memo — WESTERN MISSOURI MEDICAL CENTER 2026-04-26 09:55 UTC
IC Memo — WESTERN MISSOURI MEDICAL CENTER
Investment Committee Memorandum | MO | 45 beds | Grade C | EBITDA uplift $8.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

WESTERN MISSOURI MEDICAL CENTER

CCN 260097 | JOHNSON, MO | 45 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

WESTERN MISSOURI MEDICAL CENTER is a 45-bed suburban community hospital in JOHNSON, MO with $108.5M in net patient revenue and a -9.2% operating margin. The hospital serves a payer mix of 32.3% Medicare, 8.0% Medicaid, and 59.7% commercial.

Thesis: Turnaround. Our ML models identify $8.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -9.2% to -1.9% (+736bps).

Net Revenue HCRIS$108.5M
Current EBITDA COMPUTED$-10.0M
Operating Margin COMPUTED-9.2%
Occupancy HCRIS60.9%
Revenue / Bed COMPUTED$2.4M
Net-to-Gross HCRIS33.3%
Distress Probability ML45.2%

2. Market Context & Competitive Position

138
MO Hospitals
-6.2%
State Median Margin
65
Comparable Hospitals

MO has 138 Medicare-certified hospitals with a median operating margin of -6.2%. The target's margin of -9.2% places it below the state median. Among 65 size-comparable peers (22-90 beds), the median margin is -9.1%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (22-90), prioritizing same-state peers. 65 hospitals in the comp set.

HospitalStateBedsRevenueMargin
WESTERN MISSOURI MEDICAL CENTE (Target)MO45$108.5M-9.2%
HANNIBAL REGIONAL HOSPITALMO86$226.2M-6.8%
BARNES JEWISH WEST COUNTY HOSPMO68$221.1M4.9%
CITIZENS MEMORIAL HOSPITAL DISMO52$178.3M-19.3%
LEES SUMMIT MEDICAL CENTERMO80$146.7M13.6%
GOLDEN VALLEY MEMORIAL HOSPITAMO42$139.8M-4.9%
PROGRESS WEST HOSPITALMO69$112.0M11.7%
MERCY HOSPITAL LEBANONMO43$94.1M15.5%
BELTON REGIONAL MEDICAL CENTERMO62$92.1M17.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.3M+210bp18mo
Cost to Collect4.5%2.5%$2.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.3M+122bp9mo
Clean Claim Rate88.0%96.0%$69K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.3M
Cost to Collect
$2.2M
Denial Rate Reduction
$2.1M
A/R Days Reduction
$1.3M
Clean Claim Rate
$69K
Total EBITDA Uplift$8.0M
Current EBITDA$-10.0M
+ RCM Uplift+$8.0M
Pro Forma EBITDA$-2.0M
Current Margin-9.2%
Pro Forma Margin-1.9%
WC Released (1x)$4.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-15.4M$13.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-15.4M$10.2M0.00x-100.0%
Bull Case9.0x11.0x$-13.8M$31.6M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-13.8M$30.4M0.00x-100.0%
Bear Case11.0x10.0x$-16.9M$-21.1M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-16.9M$-28.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 65 hospitals with 22-90 beds
  • Same-state prioritization (n=66)
  • Comp margins: P25=-16.3% / P50=-9.1% / P75=5.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.